Welcome to Markets Desk, your midday read on what's moving and why.
Memory chips are rewriting the record books. SK Hynix crossed the one trillion dollar valuation threshold today, less than twenty four hours after Micron hit the same mark. The back to back milestones reflect an AI-driven demand surge in high bandwidth memory, with at least one major bank now arguing the AI trade is actually underhyped rather than stretched.
That view finds some support from Goldman Sachs, which raised its S and P five hundred price target today while pushing back hard on bubble comparisons. Goldman acknowledges speculative activity is elevated, but argues it has not reached the kind of extreme readings that historically precede sharp market corrections. The call carries weight given how loudly the bubble debate has been growing on desks across the street.
And speaking of valuations, Precision BioSciences reported what could be a genuinely significant clinical milestone, releasing the first human evidence that a therapeutic agent can directly eliminate cccDNA, the stubborn viral reservoir that makes hepatitis B so difficult to cure. Shares moved sharply higher on the data, which came from the company's ELIMINATE-B study and represents a meaningful step forward in functional cure research.
That's the tape. Markets Desk, signing off the floor.
